Nicoletta C.
- Country
- Italy
- Department
- Divisione di Ginecologia Oncologica
Research Overview
- A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
- Phase 2 Study of ACR-368 and Gemcitabine in Subjects with Endometrial Cancer
- Phase 3 Study Comparing Rinatabart Sesutecan Versus Investigator's Choice in Patients With Recurrent or Progressive Endometrial Cancer Following Platinum-Based and PD(L)-1 Therapy
Data & Insights
Has run more than one trial at 298 of 479 partner sites.
Specializations
Ovarian Cancer Research
This investigator specializes in conducting clinical trials for high-grade serous ovarian cancer, fallopian tube cancer, and primary peritoneal cancer. Their research encompasses both platinum-resistant and BRCA-mutated variants of these conditions.
- Advanced epithelial ovarian cancer treatments
- Low-grade serous ovarian cancer therapies
- Novel combination treatment approaches
Endometrial Cancer Studies
The investigator conducts extensive research in advanced endometrial cancer treatments, including studies of immunotherapy approaches and targeted therapies for various stages of the disease.
- First-line treatment strategies
- Recurrent endometrial cancer management
- MMR-deficient endometrial cancer therapies
Cervical Cancer Innovation
Research focuses on developing treatments for locally advanced cervical cancer and metastatic cervical carcinoma, incorporating novel therapeutic approaches and combination strategies.
- Chemoradiotherapy combinations
- Immunotherapy applications
- Treatment strategies for recurrent disease
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.